Diese Veranstaltung hat bereits stattgefunden

Kongress

Inflammatio 2018

2nd International Colloquium on Intraocular Inflammation
64432 Tel Aviv-Yafo, Israel
Veranstaltungsnummer: 27913
Gebühren ab: 170,00 USD
verfügbare Plätze: unbegrenzt
Sprache: Englisch

 Zum Kalender hinzufügen
  • Datum
    26.11.2018, 17:30 - 29.11.2018, 14:30
    Veranstalter
    International Uveitis Study Group (IUSG)
    Kurzbeschreibung
    Inflammatio 2018 that will take place in Tel Aviv, Israel from the 27th to the 29th of November.The idea of inflammatio is to have a high standard forum for discussing challenging uveitis topics. The program will include important aspects in diagnostics, surgery and treatment. We would like to invite you to participate actively in the meeting, since the core of the meeting is aimed to have lots of discussions. Your active participation is no doubt critical for the success of the meeting.
    Gebühren

    alle

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    170,00 USD
    Hinweis
    On-Site Registration:

    1 day participation: $ 170
    3 day participation: $ 450
  • MON, 26 November 2018    
         
    17:30 - 19:00 Welcome reception in the Dan Hotel  
         
    TUE, 27 November 2018    
         
    08:15 - 09:00 Registration  
    09:00 - 09:05 Opening  
         
      Experimental Uveitis Models in 2018  
         
    09:05 - 09:25 Regulation of Th17 response by IL-17:
    implications for autoimmunity 
    Rachel Caspi
    09:25 - 09:45 Lessons from experimental rat models for
    chronic and relapsing autoimmune uveitis
    Gerhild Wildner
    09:45 - 10:05 Of mice and men and women James Rosenbaum
    10:05 - 10:20 Discussion  
         
      The Role of Microbiome in Uveitis  
         
    10:45 - 11:00 Welcome to the World of Microbiota Nida Sen
    11:00 - 11:18 Microbiome and the Eye-the good and the bad Rachel Caspi
    11:18 - 11:38 Microbiome and Tuberculosis Florian Hoelzl​
    11:38 - 11:56 Microbiome and HLA-B27 James Rosenbaum
    11:56 - 12:16 Virome and the Eye Jolanda D.F de Groot-Mijnes
    12:16 - 12:30 Discussion  
         
      Multimodal Imaging (MMI) for Inflammatory Outer Retinopathies  
         
    13:30 - 13:42 What have we learned from MMI about
    inflammatory outer retinopathies
    Michal Kramer
    13:42 - 13:54 Insights to outer retinopathies from OCTA and Adaptive Optics Padmamalini Mahendradas
    13:54 - 14:04 Clues for inflammation by MMI of rarest entities Orly Gal-Or
    14:04 - 14:16 Clinical application of Artificial Intelligence and Machine Learning Noam Bresiz
    14:16 - 14:26 The way to use Artificial Intelligence and
    machine learning in Uveitis Diagnosis
     Antoine Brezin
    14:26 - 14:36 How MMI changes our management of
    inflammatory outer retinopathies
    Padmamalini Mahendradas
    14:36 - 14:45 Discussion  
         
    15:15 - 16:15 Controversies  
         
      1. Systemic vs intraocular steroid therapy
    for acute toxoplasmic retinochoroiditis 
    pro systemic: Emmett Cunningham
    pro intraocular: Rubens Belfort
      2. Biologics vs immunosuppressives as
    first line treatment for JIA-induced uveitis
    pro Biologics: Athimalaipet V. Ramanan
    pro Immunosuppressives: Debra Goldstein
      3. Treatment of Behcet´s Disease: anti-TNF vs interferon alpha pro: anti-TNF-alpha: Shiri Shulman
    pro: interferon alpha: Manfred Zierhut
         
      Progression Markers  
         
    16:15 - 16:25 Progression markers of Vogt Koyanagi Haradas Disease Nobuyoshi Kitaichi 
    16:25 - 16:35 Biomarkers for increased risk of developing uveitis in JIA Joke de Boer
    16:35 - 16:45 Laser flare photometry can predict a recurrence in Behçet-uveitis Nilüfer Yalcindag
    16:45 - 17:00 Discussion  
         
    WED, 28 November 2018    
         
    08:30 - 09:00 Registration (new participants)  
         
      Tuberculosis - From Infection to Inflammation  
         
    09:00 - 09:12 Immunology of general TB infection  Florian Hoelzl​
    09:12 - 09:24 Immunology of ocular TB infection  Soumyava Basu
    09:24 - 09:36 Update of the the COTS-studies Reema Bansal
    09:36 - 09:48 Clinical spectrum of “inflammatory” TB  Vasconcellos-Santos D​aniel
    09:48 - 10:00 Quantiferon testing in endemic vs. non-endemic areas Soon Phaik Chee
    10:00 - 10:15 Discussion  
         
      Preparing for Intraocular Surgery in Uveitis Patients  
         
    10:45 - 11:00 General principles of medical preparation for
    intraocular surgery in uveitis
     
    11:00 - 11:15 Intra- and perioperative care during cataract surgery  
    11:15 - 11:30 Preparing for glaucoma drainage and vitrectomy in uveitis  
    11:30 - 12:30 Round Table  Moderator: Nicholas Jones Cristina Muccioli,
    Nisha Acharya, Matthias Becker
         
      Uveitis Related Macular Edema  
         
    13:30 -13:50 Differences between Uveitis macular edema and other etiologies Francine Behar Cohen 
    13:50 - 14:00 Role of Cytokines in uveitis related CME  Marina Mesquida
    14:00 - 14:15 Macular edema-what have the MUST trials taught us Sue Lightman
    14:15 - 14:30  Options for treatment of uveitis related CME Marina Mesquida
    14:30 - 14:40 Biologics and uveitic CME Oren Tomkins
    14:40 - 15:00 Discussion  
         
      Future Protocols for Uveitis Trials  
         
    15:30 - 15:35 Introduction Philip Murray
    15:35 - 15:50 The Problem of outcome measurements in uveitis trials Nisha Acharya
    15:50 - 06:03 Clinical trials in uveitis-The Industry Perspective Ron Neuman
    16:03 - 16:16 Clinical trials in uveitis-The Reading Center Perspective Marion Munk 
    16:16 - 16:29 Why previous uveitis trials often failed James Rosenbaum
    16:29 - 17:00 Round Table: What would be your ideal uveitis trial Moderator: Philip Murray
         
    THU, 29. November 2018    
         
    08:30 - 09:00 Registration (new participants)  
         
      Biologic Agents for Uveitis  
         
    09:00 - 09:12 Definition of “Failure” under biologic drugs  Debra Goldstein
    09:12 - 09:24 Biologics inducing uveitis Manfred Zierhut
    09:24 - 09:36 Side effects of biologics and biosimilars  Martin van Hagen
    09:36 - 09:48 Off label biologics as the next step Eric Suhler
    09:48 - 10:15 Discussion  
         
    10:45 - 12:00 Case Reports Chairs: Careen Lowder, Massimo Accorinti,
    Zohar Habot-Wilner
        Mystery Cases - Israeli Uveitis Group
         
    12:00 - 12:30 Presentation of the best 5 Posters  
         
      Uveitis in Immune Incompetent Patients  
         
    13:30 - 13:42 AIDS associated Uveitis in 2018  Jyotirmay Biswas
    13:42 - 13:54 Role of CMV in immune incompetence  Alejandra dela Torre
    13:54 - 14:06 Post-Transplantation-Lymphoproliferative disorders Manfred Zierhut
    14:06 - 14:18 Immune mediated ocular toxicity following the use
    of Immune Checkpoint Inhibitors for malignancy
    Nida Sen
    14:18 - 14:30 Carcinoma-associated Uveitis Radgonde Amer

    Rahmenprogramm

    Tour to Jerusalem:

    Sunday, November 25th.
    Meeting Point&Time : 8AM leaves Dan Tel Aviv Hotel
    Tour includes: an English speaking guide, transportation from the Dan Tel Aviv Hotel, light meal + beverage.
    Price: $100 per person. Price based on participation of 15 people and may change according to the number of participants.
    Entry fees may be required.

    Monday 26/11 : 17.30-19.00 Welcome reception at the Dan hotel

    Tuesday 27/11 : 17.00 -19.00 Meeting cocktail at the Dan hotel

     

    Tel Aviv Walking Tour:

    Friday, November 30th
    Meeting Point&Time : 9AM , Dan Tel-Aviv Hotel
    Tour includes: an English speaking guide
    Price : $55 per person. Price based on participation of 10 people and may change according to the number of participants.
    Entry fees may be required.

  • Dan Tel Aviv Hotel

    International Uveitis Study Group (IUSG)

  •  

    Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter.